135 related articles for article (PubMed ID: 23009927)
1. F(2)-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome.
Durand T; De Felice C; Signorini C; Oger C; Bultel-Poncé V; Guy A; Galano JM; Leoncini S; Ciccoli L; Pecorelli A; Valacchi G; Hayek J
Biochimie; 2013 Jan; 95(1):86-90. PubMed ID: 23009927
[TBL] [Abstract][Full Text] [Related]
2. F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome.
De Felice C; Signorini C; Durand T; Oger C; Guy A; Bultel-Poncé V; Galano JM; Ciccoli L; Leoncini S; D'Esposito M; Filosa S; Pecorelli A; Valacchi G; Hayek J
J Lipid Res; 2011 Dec; 52(12):2287-2297. PubMed ID: 21917727
[TBL] [Abstract][Full Text] [Related]
3. F₄-neuroprostanes mediate neurological severity in Rett syndrome.
Signorini C; De Felice C; Leoncini S; Giardini A; D'Esposito M; Filosa S; Della Ragione F; Rossi M; Pecorelli A; Valacchi G; Ciccoli L; Hayek J
Clin Chim Acta; 2011 Jul; 412(15-16):1399-406. PubMed ID: 21530498
[TBL] [Abstract][Full Text] [Related]
4. Systemic oxidative stress in classic Rett syndrome.
De Felice C; Ciccoli L; Leoncini S; Signorini C; Rossi M; Vannuccini L; Guazzi G; Latini G; Comporti M; Valacchi G; Hayek J
Free Radic Biol Med; 2009 Aug; 47(4):440-8. PubMed ID: 19464363
[TBL] [Abstract][Full Text] [Related]
5. Dihomo-isoprostanes-nonenzymatic metabolites of AdA-are higher in epileptic patients compared to healthy individuals by a new ultrahigh pressure liquid chromatography-triple quadrupole-tandem mass spectrometry method.
Medina S; Miguel-Elízaga ID; Oger C; Galano JM; Durand T; Martínez-Villanueva M; Castillo ML; Villegas-Martínez I; Ferreres F; Martínez-Hernández P; Gil-Izquierdo Á
Free Radic Biol Med; 2015 Feb; 79():154-63. PubMed ID: 25464272
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in Rett syndrome: natural history, genotype, and variants.
Leoncini S; De Felice C; Signorini C; Pecorelli A; Durand T; Valacchi G; Ciccoli L; Hayek J
Redox Rep; 2011; 16(4):145-53. PubMed ID: 21888765
[TBL] [Abstract][Full Text] [Related]
7. F2-dihomo-isoprostanes arise from free radical attack on adrenic acid.
VanRollins M; Woltjer RL; Yin H; Morrow JD; Montine TJ
J Lipid Res; 2008 May; 49(5):995-1005. PubMed ID: 18250368
[TBL] [Abstract][Full Text] [Related]
8. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome.
De Felice C; Della Ragione F; Signorini C; Leoncini S; Pecorelli A; Ciccoli L; Scalabrì F; Marracino F; Madonna M; Belmonte G; Ricceri L; De Filippis B; Laviola G; Valacchi G; Durand T; Galano JM; Oger C; Guy A; Bultel-Poncé V; Guy J; Filosa S; Hayek J; D'Esposito M
Neurobiol Dis; 2014 Aug; 68(100):66-77. PubMed ID: 24769161
[TBL] [Abstract][Full Text] [Related]
9. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
Mas E; Michel F; Guy A; Bultel V; Falquet Y; Chardon P; Rossi JC; Cristol JP; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):133-40. PubMed ID: 18706873
[TBL] [Abstract][Full Text] [Related]
10. Measurement of urinary F(2)-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances.
Mas E; Barden A; Durand T; Galano JM; Croft KD; Mori TA
Free Radic Res; 2010 Feb; 44(2):191-8. PubMed ID: 19929242
[TBL] [Abstract][Full Text] [Related]
11. Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans.
Hsieh YP; Lin CL; Shiue AL; Yin H; Morrow JD; Hsu JC; Hsieh TC; Wei HJ; Yen HC
Free Radic Biol Med; 2009 Sep; 47(6):814-24. PubMed ID: 19555757
[TBL] [Abstract][Full Text] [Related]
12. Potential applications of lipid peroxidation products - F
De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure.
Cracowski JL; Carpentier PH; Imbert B; Cachot S; Stanke-Labesque F; Bessard J; Bessard G
Arthritis Rheum; 2002 May; 46(5):1319-23. PubMed ID: 12115239
[TBL] [Abstract][Full Text] [Related]
14. Increased isoprostanoid levels in brain from murine model of Krabbe disease - Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity.
Signorini C; Cardile V; Pannuzzo G; Graziano ACE; Durand T; Galano JM; Oger C; Leoncini S; Cortelazzo A; Lee JC; Hayek J; De Felice C
Free Radic Biol Med; 2019 Aug; 139():46-54. PubMed ID: 31100476
[TBL] [Abstract][Full Text] [Related]
15. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.
Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Franke A; Roberts LJ; Milne G; Zheng W; Dai Q
Am J Clin Nutr; 2012 Aug; 96(2):405-14. PubMed ID: 22760572
[TBL] [Abstract][Full Text] [Related]
16. Isoprostane as a marker of oxidative stress in chronic heroin users: correlation with duration of heroin use or concomitant hepatitis C infection.
Kovatsi L; Njau S; Nikolaou K; Tsolakidou A; Karamouzis I; Thisiadou K
Am J Drug Alcohol Abuse; 2010 Jan; 36(1):13-7. PubMed ID: 20141391
[TBL] [Abstract][Full Text] [Related]
17. Assessment of oxidative stress biomarkers - neuroprostanes and dihomo-isoprostanes - in the urine of elite triathletes after two weeks of moderate-altitude training.
García-Flores LA; Medina S; Cejuela R; Martínez-Sanz JM; Oger C; Galano JM; Durand T; Casas-Pina T; Martínez-Hernández P; Ferreres F; Gil-Izquierdo Á
Free Radic Res; 2016; 50(5):485-94. PubMed ID: 26503242
[TBL] [Abstract][Full Text] [Related]
18. MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.
Signorini C; De Felice C; Leoncini S; Møller RS; Zollo G; Buoni S; Cortelazzo A; Guerranti R; Durand T; Ciccoli L; D'Esposito M; Ravn K; Hayek J
PLoS One; 2016; 11(3):e0150101. PubMed ID: 26930212
[TBL] [Abstract][Full Text] [Related]
19. Subclinical myocardial dysfunction in Rett syndrome.
De Felice C; Maffei S; Signorini C; Leoncini S; Lunghetti S; Valacchi G; D'Esposito M; Filosa S; Della Ragione F; Butera G; Favilli R; Ciccoli L; Hayek J
Eur Heart J Cardiovasc Imaging; 2012 Apr; 13(4):339-45. PubMed ID: 22113206
[TBL] [Abstract][Full Text] [Related]
20. F2-isoprostanes are not just markers of oxidative stress.
Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
